JLE

Epileptic Disorders

MENU

Rufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice Volume 20, issue 1, February 2018

TEST YOURSELF

(1) What are the three features that are commonly thought to characterise Lennox-Gastaut syndrome?

 

(2) Which seizure type, commonly associated with Lennox-Gastaut syndrome, is rufinamide considered to be particularly effective in treating?

 

(3) Which of the following is not one of the most common side effects of rufinamide treatment?

A. Somnolence

B. Weight increase

C. Fatigue

 

 

 

 

 

 

See answers

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Answers

(1) (1) Multiple seizure types that include tonic seizures, (2) abnormal EEG features with slow spike-wave discharges, (3) cognitive impairment, often accompanied by behavioural problems.


(2) Tonic-atonic seizures (drop attacks).

 

(3) B.

 

 Back to questions